Each day during our coverage of the 3rd World Parkinson Congress, we ask our WPC reporters, “What’s the most interesting thing you heard or saw today?” Here are a few answers from Wednesday, October 2, Day One.
The 3rd World Parkinson Congress includes three days of sessions discussing the latest in Parkinson’s science and care. PDF’s reporters are listening in and reporting back to let you know what they have seen and heard. In particular, PDF Research Advocates Kim and Libbe Erickson of Stillwater, MN, were busy yesterday reporting on three sessions – covering treatments such as levodopa, the search for biomarkers and updates on deep brain stimulation. Here are their reports:
Each day during our coverage of the 3rd World Parkinson Congress, we ask our WPC reporters, “What’s the most interesting thing you heard or saw today?” Here are three answers from pre-congress days, Monday, September 30 and Tuesday, October 1 (called Day 0).
A lawyer, a film executive, a reality TV show winner and a stuffed raccoon named Parky. Last night’s opening ceremony of the 3rd World Parkinson Congress was not only varied, but it was also moving, inspiring and energizing.
From Linda Morgan, M.B.A., R.Ph., member People with Parkinson’s Advisory Council I arrived early in Montreal for the 3rd World Parkinson Congress, which will officially start on Tuesday. I came in early to be part of an ‘historic’ dinner and meeting between researchers from the Parkinson Study Group (PSG) and those of us involved with Parkinson’s Advocates in Research (PAIR).
By Peggy Willocks, member, PDF People with Parkinson’s Advisory Council April is Parkinson’s Awareness Month. And it won’t be newsworthy that I came all the way from Tennessee to New York to participate in this past Saturday’s Parkinson’s Unity Walk, where about 10,000 people with Parkinson’s, friends and family “walked” through Central Park as a symbolic gesture to raise funding for research. As a member of the Parkinson’s Disease Foundation’s (PDF) Advisory Council, it isn’t newsworthy that I am also here as a voice of the patient in helping to have better and faster approval of therapies for the debilitating… Read More